2,083
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Comparative in vitro study on the local tolerance and efficacy of benzalkonium chloride, myristalkonium chloride and nonoxynol-9 as active principles in vaginal contraceptives

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , , , , ORCID Icon & ORCID Icon show all
Pages 334-342 | Received 08 Dec 2020, Accepted 02 Mar 2021, Published online: 06 Apr 2021

References

  • Gupta G. Microbicidal spermicide or spermicidal microbicide? Eur J Contracept Reprod Health Care. 2005;10(4):212–218.
  • Fruzzetti F, Perini D, Fornaciari L, et al. Discontinuation of modern hormonal contraceptives: an Italian survey. Eur J Contracept Reprod Health Care. 2016;21(6):449–454.
  • Serfaty D. Update on the contraceptive contraindications. J Gynecol Obstet Hum Reprod. 2019;48(5):297–307.
  • Bearak J, Popinchalk A, Alkema L, et al. Global, regional, and subregional trends in unintended pregnancy and its outcomes from 1990 to 2014: estimates from a Bayesian hierarchical model. Lancet Glob Health. 2018;6(4):e380–e389.
  • Lech MM. Spermicides 2002: an overview. Eur J Contracept Reprod Health Care. 2002;7(3):173–177.
  • Batár I. State-of-the-art of non-hormonal methods of contraception: II. Chemical barrier contraceptives. Eur J Contracept Reprod Health Care. 2010;15(2):89–95.
  • Iyer V, Poddar SS. Update on nonoxynol-9 as vaginal spermicide. Eur J Contracept Reprod Health Care. 2008;13(4):339–350.
  • Vieira OV, Hartmann DO, Cardoso CM, et al. Surfactants as microbicides and contraceptive agents: a systematic in vitro study. PLoS One. 2008;3(8):e2913.
  • Inácio ÂS, Mesquita KA, Baptista M, et al. In vitro surfactant structure-toxicity relationships: implications for surfactant use in sexually transmitted infection prophylaxis and contraception. PLoS One. 2011;6(5):e19850.
  • Belec L, Tevi-Benissan C, Bianchi A, et al. In vitro inactivation of Chlamydia trachomatis and of a panel of DNA (HSV-2, CMV, adenovirus, BK virus) and RNA (RSV, enterovirus) viruses by the spermicide benzalkonium chloride. J Antimicrob Chemother. 2000;46(5):685–693.
  • Courtot AM, Nikas G, Gravanis A, et al. Effects of cholic acid and ‘Protectaid’ formulations on human sperm motility and ultrastructure. Hum Reprod. 1994;9(11):1999–2005.
  • Mauck CK, Baker JM, Barr SP, et al. A phase I comparative study of contraceptive vaginal films containing benzalkonium chloride and nonoxynol-9. Postcoital testing and colposcopy. Contraception. 1997;56(2):89–96.
  • Harrison JJ, Turner RJ, Joo DA, Stan MA, et al. Copper and quaternary ammonium cations exert synergistic bactericidal and antibiofilm activity against Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2008;52(8):2870–2881.
  • Serfaty D. Contraception in breastfeeding women: place for spermicides. J Gynecol Obstet Biol Reprod. 2015;44(1):18–27.
  • Serfaty D. Contraception during perimenopause: the spermicides option. J Gynecol Obstet Hum Reprod. 2017;46(3):211–218.
  • Aubeny E, Colau JC, Nandeuil A. Local spermicidal contraception: a comparative study of the acceptability and safety of a new pharmaceutical formulation of benzalkonium chloride, the vaginal capsule, with a reference formulation, the pessary. Eur J Contracept Reprod Health Care. 2000;5(1):61–67.
  • Fichorova RN, Bajpai M, Chandra N, et al. Interleukin (IL)-1, IL-6, and IL-8 predict mucosal toxicity of vaginal microbicidal contraceptives. Biol Reprod. 2004;71(3):761–769.
  • Marinov B. Our experience in the application of local contraceptives. Akush Ginekol. 2004;43(3):48–51.
  • Xu JX, Huang ZR, Wu Y, et al. Contraceptive efficacy of bioadhesive benzalkonium chloride gel in comparison with nonoxynol-9 gel. Zhonghua Fu Chan Ke Za Zhi. 2006;41(10):706–709.
  • Li W, Huang Z, Wu Y, et al. Effectiveness of an optimized benzalkonium chloride gel as vaginal contraceptive: a randomized controlled trial among Chinese women. Contraception. 2013;87(6):756–765.
  • Arambasić BM, Subotin ML, Stanić M. Comparative in vitro study of nonoxynol-9: effects on human, bull and boar spermatozoa. Contraception. 1992;45(3):229–237.
  • Owen DH, Katz DF. A vaginal fluid simulant. Contraception. 1999;59(2):91–95.
  • Zaveri T, Hayes JE, Ziegler GR. Release of tenofovir from carrageenan-based vaginal suppositories. Pharmaceutics. 2014;6(3):366–377.
  • World Health Organization (WHO). WHO laboratory manual for the Examination and processing of human semen. 5th ed. Geneva: WHO Press; 2010.
  • Jain RK, Jain A, Maikhuri JP, et al. In vitro testing of rationally designed spermicides for selectively targeting human sperm in vagina to ensure safe contraception. Hum Reprod. 2009;24(3):590–601.
  • Portela JM, Tavares RS, Mota PC, et al. High glucose concentrations per se do not adversely affect human sperm function in vitro. Reproduction. 2015;150(1):77–84.
  • Mota PC, Tavares RS, Cordeiro M, et al. Acute effects of TCDD administration: special emphasis on testicular and sperm mitochondrial function. Apjr. 2012;1(4):269–276.
  • Kremer J. A simple sperm penetration test. Int J Fertil. 1965;10(3):209–215.
  • Jain RK, Maikhuri JP, Kiran Kumar ST, et al. Novel disulphide esters of carbothioic acid as potent, non-detergent spermicides with low toxicity to Lactobacillus and HeLa cells in vitro. Hum Reprod. 2007;22(3):708–716.
  • Tavares RS, Portela JMD, Sousa MI, et al. High glucose levels affect spermatogenesis: an in vitro approach. Reprod Fertil Dev. 2017;29(7):1369–1378.
  • Schill WB, Wolff HH. Ultrastructure of human spermatozoa in the presence of the spermicide nonoxinol-9 and a vaginal contraceptive containing nonoxinol-9. Andrologia. 1981;13(1):42–49.
  • Tavares RS, Silva AF, Escada-Rebelo S, et al. Book of abstracts: The 15th Congress of the European Society of contraception and reproductive health. Eur J Contracept Reprod Health Care. 2018;23(sup1):60–61.
  • Erny R, Siborni C. The effect of benzalkonium chloride on ovulatory cervical mucus. Acta Eur Fertil. 1987;18(2):109–111.
  • Korting HC, Herzinger T, Hartinger A, et al. Discrimination of the irritancy potential of surfactants in vitro by two cytotoxicity assays using normal human keratinocytes, HaCat cells and 3T3 mouse fibroblasts: correlation with in vitro data from a soap chamber assay. J Dermatol Sci. 1994;7(2):119–129.
  • Herold BC, Kirkpatrick R, Marcellino D, et al. Bile salts: natural detergents for the prevention of sexually transmitted diseases. Antimicrob Agents Chemother. 1999;43(4):745–751.
  • Patton DL, Wang SK, Kuo CC. In vitro activity of nonoxynol 9 on HeLa 229 cells and primary monkey cervical epithelial cells infected with Chlamydia trachomatis. Antimicrob Agents Chemother. 1992;36(7):1478–1482.
  • Rustomjee R, Abdool Karim Q, Abdool Karim SS, et al. Phase 1 trial of nonoxynol-9 film among sex workers in South Africa. AIDS. 1999;13(12):1511–1515.
  • Roddy RE, Cordero M, Cordero C, et al. A dosing study of nonoxynol-9 and genital irritation. Int J STD Aids. 1993;4(3):165–170.
  • Richardson BA, Lavreys L, Martin HL, Jr, et al. Evaluation of a low-dose nonoxynol-9 gel for the prevention of sexually transmitted diseases: a randomized clinical trial. Sex Transm Dis. 2001;28(7):394–400.
  • WHO/CONRAD Technical Consultation on Nonoxynol-9. Geneva: WHO; Summary Report 9–10 October 2001.
  • Creatsas G, Guerrero E, Guilbert E, et al. A multinational evaluation of the efficacy, safety and acceptability of the Protectaid contraceptive sponge. Eur J Contracept Reprod Health Care. 2001;6(3):172–182.